Leukemia Clinical Trials in Maryland

Showing 501-520 of 899 trials

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT01647971

The purpose of this study is to determine whether ublituximab is safe and effective in patients with relapsed or refractory B-cell lymphoma who were previously treated with rituximab.

Non-Hodgkins LymphomaB-cell LymphomaWaldenstrom's Macroglobulinemia+4 more

TG Therapeutics, Inc.39 participantsStarted Jul 2012

Huntsville, Alabama, United States • Jonesboro, Arkansas, United States • Athens, Georgia, United States +5 more locations

COMPLETED17 miles

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01005368

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at biomarkers in blood and bone marrow samples from patients with previously untreated chronic lymphocytic leukemia.

Leukemia

Alliance for Clinical Trials in Oncology600 participantsStarted Oct 2009

San Diego, California, United States • Lewes, Delaware, United States • Newark, Delaware, United States +32 more locations

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

Leukemia Trials in Other Cities

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Predictive Assay for Decision Making in Adjuvant Therapy

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

A Study of LY3023414 in Participants With Advanced Cancer

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Other Conditions in Maryland